---
title: SeerPharma Journal - July 2023
description: AI/LLMS impact on Quality & GMP, Pharma Mfg Future, PIC/S Annex 16 in AUS, CSA/CSV & 21 CFR Part 11 Training, TGA GMP Inspection Support, QP Audits in APAC
image: https://content.seerpharma.com/hubfs/Images/Journal/Pharmaceutical%20Operators%20with%20Mixing%20Equipment.png
---

[![SeerPharma Master Logo](https://content.seerpharma.com/hs-fs/hubfs/Master%20SeerPharma%20Logo%20PNG%20(Web).png?width=1413&height=279&name=Master%20SeerPharma%20Logo%20PNG%20(Web).png "SeerPharma Master Logo")](https://www.seerpharma.com/?hsLang=en-au)

# Download Your July 2023 SeerPharma Journal!

![Journal-Cover-2023-July](https://content.seerpharma.com/hs-fs/hubfs/Images/Journal_Covers/Journal-Cover-2023-July.png?width=248&height=351&name=Journal-Cover-2023-July.png)

 

Submit the form to the right to access our second edition of the SeerPharma Journal for 2023 with articles on:

- SeerPharma and Melbourne University Assess Impact of AI/LLMS on Quality and GMP
- What Is the Future of the Pharma Manufacturing Industry?
- The Impact of Annex 16 Adoption by PIC/S in Australia
- Global Diagnostics Manufacturer Engages SeerPharma for CSA/CSV and 21 CFR Part 11 Training
- TGA GMP Inspection Assistance for Indian and Indonesian Firms
- SeerPharma Engaged for European QP Audits in APAC
- Online Training and Webinars

#### About Us

SeerPharma is a team of consultants that provide advice, training, IT solutions and contract labour resources to pharmaceutical, medical device, life science manufacturers and other regulated industries to advance Quality and GMP best-practices in the Asia-Pacific region.

#### Locations

[fa icon="home"]  Level 3 / 439 Canterbury Road, Surrey Hills, Victoria, 3127, Australia.   

[fa icon="home"]  2 Venture Drive #24-01, Vision Exchange, Singapore, 608526. 

 Copyright 2026 | SeerPharma

[[fa icon="chevron-up"]](https://content.seerpharma.com/journal-july-2023#)